Kadmon Holdings, Inc. (21)

Browse by Contract Category

Contracts

First Supplemental Indenture, dated as of November 9, 2021, by and between Kadmon Holdings, Inc. and U.S. Bank National Association, as Trustee (Filed With SEC on November 9, 2021)
Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, dated September 7, 2021 (Filed With SEC on September 8, 2021)
Agreement and Plan of Merger, dated as of September 7, 2021, by and among Kadmon Holdings, Inc., Sanofi and Latour Merger Sub, Inc (Filed With SEC on September 8, 2021)
1st Amendment to the Antibody Library License Agreement dated July 22, 2015, between Dyax Corp. and Kadmon Pharmaceuticals, LLC (Filed With SEC on March 4, 2021)
Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, dated September 7, 2021 (Filed With SEC on September 8, 2021)
Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, M.D., dated September 7, 2021 (Filed With SEC on September 8, 2021)
Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on May 12, 2021)
Amendment to Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, effective January 1, 2021 (Filed With SEC on March 4, 2021)
Amendment to Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, effective January 1, 2021 (Filed With SEC on March 4, 2021)
Amendment to Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, effective January 1, 2021 (Filed With SEC on March 4, 2021)
Antibody License Agreement, dated July 22, 2011, between Dyax Corp. and Kadmon Pharmaceuticals, LLC (Filed With SEC on March 4, 2021)
Description of the Companys Common Stock (Filed With SEC on March 4, 2021)
Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, M.D., dated effective as of January 1, 2020 (Filed With SEC on March 5, 2020)
Description of the Companys Common Stock (Filed With SEC on March 5, 2020)
Underwriting Agreement, dated November 13, 2019, by and among Kadmon Holdings, Inc., Jefferies LLC and Cantor Fitzgerald & Co., as representatives of the underwriters listed... (Filed With SEC on November 14, 2019)
Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, effective as of August 30, 2019 (Filed With SEC on November 7, 2019)
Separation Agreement and General Release between Kadmon Corporation, LLC and Steven N. Gordon, effective as of August 30, 2019 (Filed With SEC on November 7, 2019)
Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, dated effective as of February 8, 2019 (Filed With SEC on May 9, 2019)
Separation and Release Agreement between Kadmon Corporation, LLC and Konstantin Poukalov, dated November 30, 2018 (Filed With SEC on March 7, 2019)
Sixth Waiver Agreement to Credit Agreement, dated March 6, 2019, by and among Kadmon Pharmaceuticals, LLC, the guarantors party thereto and Perceptive Credit Holdings, L.P (Filed With SEC on March 7, 2019)
Form of Performance Stock Option Agreement under Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on March 7, 2019)